Results
eNauka >
Results >
Impower110: Interim Overall Survival (OS) Analysis of a Phase Iii Study of Atezolizumab (Atezo) Monotherapy Vs Platinum-Based Chemotherapy (Chemo) as First-Line (1L) Treatment in PD-L1-Selected NSCLC
| Title: | Impower110: Interim Overall Survival (OS) Analysis of a Phase Iii Study of Atezolizumab (Atezo) Monotherapy Vs Platinum-Based Chemotherapy (Chemo) as First-Line (1L) Treatment in PD-L1-Selected NSCLC | Authors  : | Herbst, Roy S; ...; Andric, Zoran G   ; ...; (broj, koautora 20) |
Issue Date: | 2020 | Publication: | JOURNAL FOR IMMUNOTHERAPY OF CANCER | ISSN: | 2051-1426 Journal for ImmunoTherapy of Cancer Search Idenfier |
Type: | Conference Paper | Collation: | vol. 8 str. A1-A1 | DOI: | 10.1136/LBA2019.1 | WoS-ID: | 000540356400002 | URI: | https://enauka.gov.rs/handle/123456789/811779 | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.